Impact on prevention and control of non-communicable disease during COVID-19 pandemic

WANG Wei-dong; HU Yi-song

doi:10.16462/j.cnki.zhjbkz.2021.04.001

Volume 25 Issue 4

May 2021

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2021 > 25(4): 373-375

WANG Wei-dong, HU Yi-song. Impact on prevention and control of non-communicable disease during COVID-19 pandemic[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(4): 373-375. doi: 10.16462/j.cnki.zhjbkz.2021.04.001

Citation:

WANG Wei-dong, HU Yi-song. Impact on prevention and control of non-communicable disease during COVID-19 pandemic[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(4): 373-375. doi: 10.16462/j.cnki.zhjbkz.2021.04.001

Citation:

PDF( 782 KB)

Impact on prevention and control of non-communicable disease during COVID-19 pandemic

doi: 10.16462/j.cnki.zhjbkz.2021.04.001

WANG Wei-dong,
HU Yi-song^,

National Survey Research Center, Renmin University of China, Beijing 100872, China

Funds: Special Funds for Central Universities to Build World-Class Universities (Disciplines) and their Distinctive Development

More Information

Corresponding author: HU Yi-song, E-mail: huysnsrc@ruc.edu.cn
Received Date: 2021-02-21
Rev Recd Date: 2021-03-13

Available Online: 2021-05-11

Publish Date: 2021-04-10

Abstract

Abstract

Since the first COVID-19 patient was reported in December of 2019, COVID-19 pandemic caused huge challenge to global health. When the world is combating the COVID-19 pandemic, more and more researches are concerning about the possible impact of COVID-19 on non-communicable disease (NCD). Although very little evidence-based studies were reported, the editorial reviewed tertiary prevention of NCD including causal prophylaxis, three-advancement prevention and clinical prevention. Few available evidences showed that COVID-19 pandemic impacted every aspects of tertiary prevention on chronic disease and the effect size depended on COVID-19 pandemic severity in different countries or regions. In addition, the editorial provided some future strategy and direction for prevention and control of NCD.
- COVID-19,
- Prevention and control,
- Non-communicable chronic diseases

FullText(HTML)

References(13)

References

[1]	World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard[EB/OL]. (2021-02-16)[2021-02-17]. https://covid19.who.int/.
[2]	Istituto Superiore di Sanità. Characteristics of SARS-CoV-2 patients dying in Italy report based on available data on January 27th, 2021[EB/OL]. (2021-02-16)[2021-02-17]. https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_27_january_2021.pdf.
[3]	中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(2): 145-151. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003. Epidemiology Working Group for NCIP Epidemic Response. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China[J]. Chin J Epidemiol, 2020, 41(2): 145-151. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003.
[4]	Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area[J]. JAMA, 2020, 323(20): 2052-2059. DOI: 10.1001/jama.2020.6775.
[5]	Venema V. Coronavirus: should I worry about my lockdown eating?[EB/OL]. (2020-04-24)[2021-02-17]. https://www.bbc.com/news/stories-52329529.
[6]	Jia P, Zhang L, Yu WQ, et al. Impact of COVID-19 lockdown on activity patterns and weight status among youths in China: the COVID-19 impact on lifestyle change survey (COINLICS)[J]. Int J Obes (Lond), 2021, 45(4): 920. DOI: 10.1038/s41366-020-00736-8.
[7]	Wright A, Salazar A, Mirica M, et al. The invisible epidemic: neglected chronic disease management during COVID-19[J]. J Gen Intern Med, 2020, 35(9): 2816-2817. DOI: 10.1007/s11606-020-06025-4.
[8]	WHO. Delivering NCD services in a time of COVID-19 - stories from the field[EB/OL]. (2020-06-03)[2021-02-17]. https://www.euro.who.int/en/countries/italy/news/news/2020/6/delivering-ncd-services-in-a-time-of-COVID-19-stories-from-the-field.
[9]	Fastenberg JH, Bottalico D, Kennedy WA, et al. The impact of the pandemic on otolaryngology patients with negative COVID-19 status: commentary and insights from orbital emergencies[J]. Otolaryngol Head Neck Surg, 2020, 163(3): 444-446. DOI: 10.1177/0194599820931082.
[10]	Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in st-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic[J]. J Am Coll Cardiol, 2020, 75(22): 2871-2872. DOI: 10.1016/j.jacc.2020.04.011.
[11]	Guo H, Zhou Y, Liu X, et al. The impact of the COVID-19 epidemic on the utilization of emergency dental services[J]. J Dent Sci, 2020, 15(4): 564-567. DOI: 10.1016/j.jds.2020.02.002.
[12]	Mauro V, Lorenzo M, Paolo C, et al. Treat all COVID-19 positive patients, but do not forget those negative with chronic diseases[J]. Intern Emerg Med, 2020, 15(5): 787-790. DOI: 10.1007/s11739-020-02395-z.
[13]	Abraham DA, Vijayakumar TM, Rajanandh MG. Challenges of non-COVID-19 patients with chronic illness during the pandemic[J]. J Res Pharm Pract, 2020, 9(3): 155-157. DOI: 10.4103/jrpp.JRPP_20_64.